top of page

Results of the GA-40 Studies

Preclinical and clinical trials in 8 different countries have confirmed the quality, safety and effectiveness of GA-40.

 

 

GA-40 has passed preclinical and clinical trials in the following organizations:

 

• Medical and biological research center - LLC Company "Alexis".

• National Cancer Center named after Gvamichava.

• Clinical Experimental Research Institute of Tbilisi State Medical University.

• Skin and Venereal Dispensary No. 1 of the Ministry of Labor, Health and Social Protection of Georgia.

• Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Sciences of Ukraine.

• Department of Biochemistry, Ukrainian State University.

• Bukovina State Medical University, Chernivtsi, Ukraine.

• Cancer Center of the Ukrainian Medical Academy, Ukraine.

• Laboratory of Cellular Signaling Mechanisms. Paladin of the National Academy of Sciences of Ukraine.

• Medical Research Institute of Physical Chemistry, Ministry of Health of Russia, Russian Federation.

• Department of Pharmacology, Medical University of the Russian Federation, Russian Federation.

• Pharmaceutical company Otsuka, Japan.

• Tokushima Institute of Cell Technology, Japan.

• Fuji Memorial Institute for Preclinical Research, Biwako, Japan.

• Research Institute for New Drugs Research and Safety Assessment, Tokushima, Japan.

• University of Washington, School of Medicine, Department of Cancer Research, Department of Pathology, Seattle, USA.

• Center for Quantum Genetics, Diagnostics and Therapy "Molecule", Zagreb, Croatia.

• Pharmaceutical company Follium xp, California, USA.

• Pharmaceutical division of the "Mega Alliance" Co., Zurich, Switzerland.

View

Medical & Biological Scientific - Research Center“ALEXIS” LTD

© Alexis ltd. 2015. All Rights Reserved. The use of the information on this site is subject to the terms of our Legal Notice. This site is published by Alexis ltd, which is solely responsible for its contents. Product names are trademarks of Alexis ltd. This information is intended for use by our customers, patients, and healthcare professionals. Alexis ltd recognizes that the internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside Georgia.

bottom of page